Global


International PwC Sites
Click the 'X' in the top right corner to close this window.
  • Home
  • Industry sectors
    • Aerospace & defence
    • Asset management
    • Automotive
    • Banking & capital markets
    • Capital projects and infrastructure
    • Chemicals
    • Communications
    • Energy, utilities & mining
    • Engineering & construction
    • Entertainment & media
    • Financial services
    • Forest, paper & packaging
    • Government/public services
    • Healthcare
    • Hospitality & leisure
    • Industrial manufacturing
    • Insurance
    • Metals
    • Pharmaceuticals & life sciences
    • Retail & consumer
    • Technology
    • Transportation & logistics
  • Today's issues
    • Governance
    • Innovation & technology
    • Operations
    • Regulation
    • Risk
    • Strategy & growth
    • Sustainability & climate change
    • Talent
  • Our services
    • Audit and assurance
    • Consulting
    • Deals
    • Human resources
    • IFRS
    • Legal
    • Middle markets and private companies
    • Sustainability & climate change
    • Tax
  • About us
    • Global Annual Review
    • Our leadership team
    • Code of conduct
    • Corporate responsibility
    • Network governance
    • Our contribution to the debate
    • Genesis Park
    • Women at PwC
    • Alumni
    • Member firms worldwide
  • Research & insights
    • Monthly highlights
    • 15th Annual Global CEO Survey
  • Careers
    • EPIC programme
  • Press room
    • Facts and figures
    • Press contacts
    • Analyst relations

Press room

21 February 2011
Patient over product: Pharma needs to prepare for the future, warns PwC

18 January 2011
Emerging markets are gaining ground in medical technology innovation; US maintains lead, finds PwC’s Medical Technology Innovation Scorecard

28 April 2010
Life sciences sector captures more than one-quarter of total venture capital dollars invested in q1 2010 but drops more than 20% from prior quarter, according to PricewaterhouseCoopers

10 February 2010
Life sciences venture capital funding overcomes record lows, outpaces other sectors, according to PricewaterhouseCoopers

  

29 June 2009
Survey finds 90% of medical device companies adopted AdvaMed's Code of Ethics, according to PricewaterhouseCoopers

30 April 2009
Challenging times require bold moves if pharma companies are to survive the immediate storm

25 February 2009
Smaller, refocused salesforce will enable pharma companies to create greater value for patients

29 January 2009
Biomedical industry becomes increasingly vital to state’s economic stability, finds California Healthcare Institute and PricewaterhouseCoopers

23 December 2008
PricewaterhouseCoopers applauds new medical device code of ethics that eliminates all gifts for doctors and lays foundation for rebuilding trust in the industry

  • Pharmaceuticals and life sciences
  • Services
  • Case studies
  • Publications
  • Pharma 2020 series
  • Press room
  • Events
  • Contacts
  • Health industries
  • CEO Survey industry summary

Contacts
Global
Simon Friend
Global leader
Pharmaceuticals and life sciences
Tel: +44 (20) 7213 4875
See full profile
Mike Swanick
Global tax leader
Pharmaceuticals and life sciences
Tel: +1 (267) 330 6060
See full profile
Dr. Steve Arlington
Global advisory leader
Pharmaceuticals and life sciences
Tel: +44 (20) 7213 4622
See full profile
Pharma 2020 series View the entire series here
  • Offices worldwide
  • Site map
  • RSS
  • Contact us
© 2009-2012 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.
  • Privacy
  • Legal
  • About site provider